Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Pliant Therapeutics

Pliant Therapeutics
2016 FOUNDED
PRIVATE STATUS
61-70 EMPLOYEES
Series C LATEST DEAL TYPE
$48.2M LATEST DEAL AMOUNT
9 INVESTORS
Description

Developer of new therapies designed to treat fibrotic disorders. The company's therapies prevent or even reverse fibrosis to address the needs of many patients, enabling patients to begin treatment more quickly and result in a higher likelihood of successful treatment.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 260 Littlefield Avenue
  • San Francisco, CA 94080
  • United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Pliant Therapeutics’s full profile, request a free trial.

Pliant Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series C) 08-Jan-2020 $48.2M 00000 00000 Completed Generating Revenue
3. Corporate 23-Oct-2019 0000 00000 Completed Generating Revenue
2. Early Stage VC (Series B) 16-Jul-2018 $62M $107M 00000 Completed Generating Revenue
1. Early Stage VC (Series A) 17-Feb-2016 $45M $45M 0000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Pliant Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 56,000,000 $0.000100 $0.08 $1 $1 1x $1 34.36%
To view this company’s complete Cap Table, request access »

Pliant Therapeutics Competitors (15)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Recursion Pharmaceuticals Venture Capital-Backed Salt Lake City, UT 000 00000 000000000 00000
00000 000000000000 Formerly VC-backed Waltham, MA 00 000.00 000000 - 000 000.00
00000 00000000 Venture Capital-Backed San Francisco, CA 00 000.00 00000000000 000.00
000000 00000000000 Venture Capital-Backed Irvine, CA 0 000.00 000000&0 000.00
000000000 Venture Capital-Backed Atlanta, GA 00 000.00 00000000000 000.00
To view this company’s complete list of competitors, request access »

Pliant Therapeutics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Novartis Corporation Minority 000 0000 000000 0
Agent Capital Venture Capital Minority 000 0000 000000 0
Cowen Healthcare Investments Venture Capital Minority 000 0000 000000 0
Eventide Asset Management Asset Manager Minority 000 0000 000000 0
Menlo Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Pliant Therapeutics Executive Team (15)

Name Title Board
Seat
Contact
Info
Bernard Coulie MD Chief Executive Officer, President & Board Member
Keith Cummings MD Chief Financial Officer
Barbara Howes Chief Human Resources Officer
Hans Hull JD Chief Business Officer
√Čric Lefebvre MD Chief Medical Officer

4 Former Executives

You’re viewing 5 of 15 executives. Get the full list »

Pliant Therapeutics Board Members (10)

Name Representing Role Since Contact
Info
Charles Homcy MD Third Rock Ventures Board Member 000 0000
Craig Muir Third Rock Ventures Board Member 000 0000
Gayle Crowell Self Board Member 000 0000
Hoyoung Huh Ph.D Self Chairman 000 0000
John Curnutte MD Self Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 10 board members. Get the full list »